BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27697099)

  • 1. High TRAF6 Expression Is Associated With Esophageal Carcinoma Recurrence and Prompts Cancer Cell Invasion.
    Liu X; Wang Z; Zhang G; Zhu Q; Zeng H; Wang T; Gao F; Qi Z; Zhang J; Wang R
    Oncol Res; 2017 Apr; 25(4):485-493. PubMed ID: 27697099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAF6 promoted the metastasis of esophageal squamous cell carcinoma.
    Han Q; Yao F; Zhong C; Zhao H
    Tumour Biol; 2014 Jan; 35(1):715-21. PubMed ID: 24026882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAF6 promoted the tumorigenicity of esophageal squamous cell carcinoma.
    Yao F; Han Q; Zhong C; Zhao H
    Tumour Biol; 2013 Oct; 34(5):3201-7. PubMed ID: 23794111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional role of asparaginyl endopeptidase ubiquitination by TRAF6 in tumor invasion and metastasis.
    Lin Y; Qiu Y; Xu C; Liu Q; Peng B; Kaufmann GF; Chen X; Lan B; Wei C; Lu D; Zhang Y; Guo Y; Lu Z; Jiang B; Edgington TS; Guo F
    J Natl Cancer Inst; 2014 Apr; 106(4):dju012. PubMed ID: 24610907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAP1 shows clinical significance and promotes cellular migration and invasion through STAT3/MMP2 pathway in human esophageal squamous cell cancer.
    Ou Y; Liu L; Xue L; Zhou W; Zhao Z; Xu B; Song Y; Zhan Q
    J Genet Genomics; 2014 Oct; 41(10):529-37. PubMed ID: 25438697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Kim SH; Kim JH; Yu EJ; Lee KW; Park CK
    Histol Histopathol; 2012 Jan; 27(1):49-58. PubMed ID: 22127596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.
    Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F
    Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of asparaginyl endopeptidase is significant for esophageal carcinoma metastasis and predicts poor patient prognosis.
    Liu X; Wang Z; Zhang G; Zhu Q; Zeng H; Wang T; Gao F; Qi Z; Zhang J; Wang R
    Oncol Lett; 2018 Jan; 15(1):1229-1235. PubMed ID: 29399177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High endothelin-converting enzyme-1 expression independently predicts poor survival of patients with esophageal squamous cell carcinoma.
    Wu CF; Lee CT; Kuo YH; Chen TH; Chang CY; Chang IW; Wang WL
    Tumour Biol; 2017 Sep; 39(9):1010428317725922. PubMed ID: 28945168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
    Li JY; Ma X; Zhang CB
    Int J Clin Exp Pathol; 2014; 7(11):7938-44. PubMed ID: 25550835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
    Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells.
    He Z; Huang C; Lin G; Ye Y
    Oncol Rep; 2016 Apr; 35(4):1933-40. PubMed ID: 26847475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.
    Nakahara Y; Yamasaki M; Sawada G; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mimori K; Mori M; Doki Y
    Oncology; 2016; 90(6):347-55. PubMed ID: 27082627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
    Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFAIP3 overexpression is an independent factor for poor survival in esophageal squamous cell carcinoma.
    Hadisaputri YE; Miyazaki T; Yokobori T; Sohda M; Sakai M; Ozawa D; Hara K; Honjo H; Kumakura Y; Kuwano H
    Int J Oncol; 2017 Mar; 50(3):1002-1010. PubMed ID: 28197630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma.
    Otsuka R; Akutsu Y; Sakata H; Hanari N; Murakami K; Kano M; Toyozumi T; Takahashi M; Matsumoto Y; Sekino N; Yokoyama M; Okada K; Shiraishi T; Komatsu A; Iida K; Matsubara H
    Oncology; 2018; 94(3):142-148. PubMed ID: 29216641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.